Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Inhaled Nitric Oxide Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global inhaled nitric oxide market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.

Inhaled nitric oxide (iNO) refers to a selective pulmonary vasodilator supervised by skilled physicians at tertiary neonatal intensive care units (NICUs). It assists in regulating vascular muscle tone and treating hypoxemic respiratory failure among newly born infants by improving ventilation-perfusion mismatch and reducing elevated pulmonary vascular resistance and hypertension. It also aids in improving oxygenation and decreasing the need for extracorporeal membrane oxygenation (ECMO). At present, there is a rise in the use of iNO therapy as a rescue agent for acute respiratory distress syndrome (ARDS) patients.

Inhaled Nitric Oxide Market Trends:

The increasing prevalence of respiratory and other subsequent diseases in newborns, such as persistent pulmonary hypertension and neonatal hypoxic respiratory failure (HRF), represents one of the primary factors significantly contributing to the market growth. Additionally, the rising geriatric population, which is relatively more prone to hypertension, atherosclerosis, peripheral artery disease, heart failure, and thrombosis, is supporting the growth of the market. Furthermore, iNO is gaining immense traction worldwide for treating chronic obstructive pulmonary diseases (COPD), asthma, and ARDS. Moreover, the outbreak of the highly contagious coronavirus disease (COVID-19) and an alarmingly increasing number of individuals getting infected on a global level are favorably influencing the market. Furthermore, iNO therapy is being used  against coronavirus stains as it assists in improving ventilation/perfusion in patients with severe pneumonia. The market is also driven by the ongoing research and development (R&D) activities in the healthcare industry around the world to improve the overall patient experience. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global inhaled nitric oxide market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region and application.

Breakup by Application:

  • Neonatal Respiratory Treatment
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Respiratory Distress Syndrome (ARDS)
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Air Liquide S.A, Bellerophon Therapeutics, Beyond Air Inc., Linde plc, Mallinckrodt plc, Merck KGaA, Novoteris LLC, Nu-Med Plus and VERO Biotech LLC.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Million
Segment Coverage Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Air Liquide S.A, Bellerophon Therapeutics, Beyond Air Inc., Linde plc, Mallinckrodt plc, Merck KGaA, Novoteris LLC, Nu-Med Plus and VERO Biotech LLC.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global inhaled nitric oxide market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global inhaled nitric oxide market?
  • What are the key regional markets?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global inhaled nitric oxide market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Inhaled Nitric Oxide Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Application
    6.1    Neonatal Respiratory Treatment
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Chronic Obstructive Pulmonary Disease (COPD)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Acute Respiratory Distress Syndrome (ARDS)
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Region
    7.1    North America
        7.1.1 United States
           7.1.1.1 Market Trends
           7.1.1.2 Market Forecast
        7.1.2 Canada
           7.1.2.1 Market Trends
           7.1.2.2 Market Forecast
    7.2    Asia-Pacific
        7.2.1 China
           7.2.1.1 Market Trends
           7.2.1.2 Market Forecast
        7.2.2 Japan
           7.2.2.1 Market Trends
           7.2.2.2 Market Forecast
        7.2.3 India
           7.2.3.1 Market Trends
           7.2.3.2 Market Forecast
        7.2.4 South Korea
           7.2.4.1 Market Trends
           7.2.4.2 Market Forecast
        7.2.5 Australia
           7.2.5.1 Market Trends
           7.2.5.2 Market Forecast
        7.2.6 Indonesia
           7.2.6.1 Market Trends
           7.2.6.2 Market Forecast
        7.2.7 Others
           7.2.7.1 Market Trends
           7.2.7.2 Market Forecast
    7.3    Europe
        7.3.1 Germany
           7.3.1.1 Market Trends
           7.3.1.2 Market Forecast
        7.3.2 France
           7.3.2.1 Market Trends
           7.3.2.2 Market Forecast
        7.3.3 United Kingdom
           7.3.3.1 Market Trends
           7.3.3.2 Market Forecast
        7.3.4 Italy
           7.3.4.1 Market Trends
           7.3.4.2 Market Forecast
        7.3.5 Spain
           7.3.5.1 Market Trends
           7.3.5.2 Market Forecast
        7.3.6 Russia
           7.3.6.1 Market Trends
           7.3.6.2 Market Forecast
        7.3.7 Others
           7.3.7.1 Market Trends
           7.3.7.2 Market Forecast
    7.4    Latin America
        7.4.1 Brazil
           7.4.1.1 Market Trends
           7.4.1.2 Market Forecast
        7.4.2 Mexico
           7.4.2.1 Market Trends
           7.4.2.2 Market Forecast
        7.4.3 Others
           7.4.3.1 Market Trends
           7.4.3.2 Market Forecast
    7.5    Middle East and Africa
        7.5.1 Market Trends
        7.5.2 Market Breakup by Country
        7.5.3 Market Forecast
8    SWOT Analysis
    8.1    Overview
    8.2    Strengths
    8.3    Weaknesses
    8.4    Opportunities
    8.5    Threats
9    Value Chain Analysis
10    Porters Five Forces Analysis

    10.1    Overview
    10.2    Bargaining Power of Buyers
    10.3    Bargaining Power of Suppliers
    10.4    Degree of Competition
    10.5    Threat of New Entrants
    10.6    Threat of Substitutes
11    Price Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Key Players
    12.3    Profiles of Key Players
        12.3.1    Air Liquide S.A
           12.3.1.1 Company Overview
           12.3.1.2 Product Portfolio
           12.3.1.3 Financials
           12.3.1.4 SWOT Analysis
        12.3.2    Bellerophon Therapeutics
           12.3.2.1 Company Overview
           12.3.2.2 Product Portfolio
           12.3.2.3 Financials
        12.3.3    Beyond Air Inc.
           12.3.3.1 Company Overview
           12.3.3.2 Product Portfolio
           12.3.3.3 Financials
        12.3.4    Linde plc
           12.3.4.1 Company Overview
           12.3.4.2 Product Portfolio
           12.3.4.3 Financials
        12.3.5    Mallinckrodt plc
           12.3.5.1 Company Overview
           12.3.5.2 Product Portfolio
           12.3.5.3 Financials
        12.3.6    Merck KGaA
           12.3.6.1 Company Overview
           12.3.6.2 Product Portfolio
           12.3.6.3 Financials
           12.3.6.4 SWOT Analysis
        12.3.7    Novoteris LLC
           12.3.7.1 Company Overview
           12.3.7.2 Product Portfolio
        12.3.8    Nu-Med Plus
           12.3.8.1 Company Overview
           12.3.8.2 Product Portfolio
           12.3.8.3 Financials
        12.3.9    VERO Biotech LLC
           12.3.9.1 Company Overview
           12.3.9.2 Product Portfolio

List of Figures

Figure 1: Global: Inhaled Nitric Oxide Market: Major Drivers and Challenges
Figure 2: Global: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Global: Inhaled Nitric Oxide Market: Breakup by Application (in %), 2020
Figure 5: Global: Inhaled Nitric Oxide Market: Breakup by Region (in %), 2020
Figure 6: Global: Inhaled Nitric Oxide (Neonatal Respiratory Treatment) Market: Sales Value (in Million US$), 2015 & 2020
Figure 7: Global: Inhaled Nitric Oxide (Neonatal Respiratory Treatment) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 8: Global: Inhaled Nitric Oxide (Chronic Obstructive Pulmonary Disease (COPD)) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Inhaled Nitric Oxide (Chronic Obstructive Pulmonary Disease (COPD)) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Inhaled Nitric Oxide (Acute Respiratory Distress Syndrome (ARDS)) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Inhaled Nitric Oxide (Acute Respiratory Distress Syndrome (ARDS)) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Inhaled Nitric Oxide (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Inhaled Nitric Oxide (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: North America: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: North America: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: United States: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: United States: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Canada: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Canada: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Asia-Pacific: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Asia-Pacific: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: China: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: China: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Japan: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Japan: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: India: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: India: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: South Korea: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: South Korea: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Australia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Australia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Indonesia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Indonesia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Europe: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Europe: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Germany: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Germany: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: France: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: France: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: United Kingdom: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: United Kingdom: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Italy: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Italy: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Spain: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Spain: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Russia: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Russia: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Latin America: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Latin America: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Brazil: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Brazil: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Mexico: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Mexico: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Others: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Others: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Middle East and Africa: Inhaled Nitric Oxide Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Middle East and Africa: Inhaled Nitric Oxide Market: Breakup by Country (in %), 2020
Figure 62: Middle East and Africa: Inhaled Nitric Oxide Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Global: Inhaled Nitric Oxide Industry: SWOT Analysis
Figure 64: Global: Inhaled Nitric Oxide Industry: Value Chain Analysis
Figure 65: Global: Inhaled Nitric Oxide Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Inhaled Nitric Oxide Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Inhaled Nitric Oxide Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 3: Global: Inhaled Nitric Oxide Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 4: Global: Inhaled Nitric Oxide Market: Competitive Structure
Table 5: Global: Inhaled Nitric Oxide Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links